History and exam

Key diagnostic factors

common

A key risk factor is female sex, aged between 20 and 50 years.

Common presenting feature in women with prolactinoma.

High prolactin inhibits ovulation in women.

Sometimes identified only during physical examination.

Hyperprolactinaemia causes secondary hypogonadism.

A particular clinical feature in men with prolactinoma.

Common presentation in men with prolactinoma.

Bilateral hemianopia occurs in patients with macroadenomas with suprasellar extension.

Other diagnostic factors

common

A consequence of low testosterone/estradiol level.

uncommon

Related to cranial nerve palsy.

Related to pituitary apoplexy (a clinical syndrome resulting from acute haemorrhagic or ischaemic infarction of a pituitary adenoma).

Risk factors

strong

Prolactin-secreting adenomas are more frequent in premenopausal women.

There is a peak incidence between 20 to 50 years of age, and an estimated ratio of frequency between women and men of 10:1.[1]

weak

Ninety-nine percent of prolactinomas are sporadic. However, pituitary adenomas, including prolactinomas, can also occur as part of MEN-1 due to germline mutations in the gene encoding menin (MEN-1). Prolactinomas also occur in the setting of FIPA due to inactivating germline mutations of the gene encoding aryl hydrocarbon receptor-interacting protein, located close to that of MEN-1, on chromosome 11q13.[8][9]

Medication-induced hyperprolactinaemia is associated with oestrogen therapy, but use of oral contraceptives or post-menopausal hormone replacement therapy does not increase susceptibility to prolactinoma development.[10]

Although prolactinomas are rare in men, if they do present in this age range it is usually with macroadenomas or they present incidentally.

Use of this content is subject to our disclaimer